Macrolide-Resistant Mycoplasma pneumoniae Infections among Children after COVID-19 Pandemic, Ohio, USA
Mycoplasma pneumoniae infections decreased in Ohio, USA, during the COVID-19 pandemic but reemerged in 2023; >2,000 cases were reported during September 2023–September 2024. Of 995 M. pneumoniae–positive samples, 24 (2.4%) had mutations for macrolide-resistant M. pneumoniae (MRMp). MRMp rates a...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Centers for Disease Control and Prevention
2025-03-01
|
| Series: | Emerging Infectious Diseases |
| Subjects: | |
| Online Access: | https://wwwnc.cdc.gov/eid/article/31/3/24-1570_article |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849705715831144448 |
|---|---|
| author | Amy L. Leber Tori Embry Kathy Everhart Jeanette Taveras Sophonie J. Oyeniran Huanyu Wang |
| author_facet | Amy L. Leber Tori Embry Kathy Everhart Jeanette Taveras Sophonie J. Oyeniran Huanyu Wang |
| author_sort | Amy L. Leber |
| collection | DOAJ |
| description |
Mycoplasma pneumoniae infections decreased in Ohio, USA, during the COVID-19 pandemic but reemerged in 2023; >2,000 cases were reported during September 2023–September 2024. Of 995 M. pneumoniae–positive samples, 24 (2.4%) had mutations for macrolide-resistant M. pneumoniae (MRMp). MRMp rates are low but increasing. MRMp surveillance is crucial for monitoring antimicrobial resistance.
|
| format | Article |
| id | doaj-art-e01d442ae80c431cb8a6e095a13e9e27 |
| institution | DOAJ |
| issn | 1080-6040 1080-6059 |
| language | English |
| publishDate | 2025-03-01 |
| publisher | Centers for Disease Control and Prevention |
| record_format | Article |
| series | Emerging Infectious Diseases |
| spelling | doaj-art-e01d442ae80c431cb8a6e095a13e9e272025-08-20T03:16:24ZengCenters for Disease Control and PreventionEmerging Infectious Diseases1080-60401080-60592025-03-0131355555810.3201/eid3103.241570Macrolide-Resistant Mycoplasma pneumoniae Infections among Children after COVID-19 Pandemic, Ohio, USAAmy L. LeberTori EmbryKathy EverhartJeanette TaverasSophonie J. OyeniranHuanyu Wang Mycoplasma pneumoniae infections decreased in Ohio, USA, during the COVID-19 pandemic but reemerged in 2023; >2,000 cases were reported during September 2023–September 2024. Of 995 M. pneumoniae–positive samples, 24 (2.4%) had mutations for macrolide-resistant M. pneumoniae (MRMp). MRMp rates are low but increasing. MRMp surveillance is crucial for monitoring antimicrobial resistance. https://wwwnc.cdc.gov/eid/article/31/3/24-1570_articleMycoplasma pneumoniaeCOVID-19respiratory infectionssevere acute respiratory syndrome coronavirus 2SARS-CoV-2SARS |
| spellingShingle | Amy L. Leber Tori Embry Kathy Everhart Jeanette Taveras Sophonie J. Oyeniran Huanyu Wang Macrolide-Resistant Mycoplasma pneumoniae Infections among Children after COVID-19 Pandemic, Ohio, USA Emerging Infectious Diseases Mycoplasma pneumoniae COVID-19 respiratory infections severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 SARS |
| title | Macrolide-Resistant Mycoplasma pneumoniae Infections among Children after COVID-19 Pandemic, Ohio, USA |
| title_full | Macrolide-Resistant Mycoplasma pneumoniae Infections among Children after COVID-19 Pandemic, Ohio, USA |
| title_fullStr | Macrolide-Resistant Mycoplasma pneumoniae Infections among Children after COVID-19 Pandemic, Ohio, USA |
| title_full_unstemmed | Macrolide-Resistant Mycoplasma pneumoniae Infections among Children after COVID-19 Pandemic, Ohio, USA |
| title_short | Macrolide-Resistant Mycoplasma pneumoniae Infections among Children after COVID-19 Pandemic, Ohio, USA |
| title_sort | macrolide resistant mycoplasma pneumoniae infections among children after covid 19 pandemic ohio usa |
| topic | Mycoplasma pneumoniae COVID-19 respiratory infections severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 SARS |
| url | https://wwwnc.cdc.gov/eid/article/31/3/24-1570_article |
| work_keys_str_mv | AT amylleber macrolideresistantmycoplasmapneumoniaeinfectionsamongchildrenaftercovid19pandemicohiousa AT toriembry macrolideresistantmycoplasmapneumoniaeinfectionsamongchildrenaftercovid19pandemicohiousa AT kathyeverhart macrolideresistantmycoplasmapneumoniaeinfectionsamongchildrenaftercovid19pandemicohiousa AT jeanettetaveras macrolideresistantmycoplasmapneumoniaeinfectionsamongchildrenaftercovid19pandemicohiousa AT sophoniejoyeniran macrolideresistantmycoplasmapneumoniaeinfectionsamongchildrenaftercovid19pandemicohiousa AT huanyuwang macrolideresistantmycoplasmapneumoniaeinfectionsamongchildrenaftercovid19pandemicohiousa |